Cargando…

Disruption of MAP7D1 Gene Function Increases the Risk of Doxorubicin-Induced Cardiomyopathy and Heart Failure

Doxorubicin is a cornerstone chemotherapeutic drug widely used to treat various cancers; its dose-dependent cardiomyopathy, however, is one of the leading causes of treatment-associated mortality in cancer survivors. Patients' threshold doses leading to doxorubicin-induced cardiomyopathy (DIC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Li-Ping, Zhong, Jing, Li, Mei-Hang, Sun, Yuan-Chao, Niu, Yu-Juan, Wu, Chuan-Hong, Zhou, Jian-Feng, Norton, Nadine, Li, Zhi-Qiang, Shi, Yong-Yong, Xu, Xiao-Lei, Ding, Yong-He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302367/ https://www.ncbi.nlm.nih.gov/pubmed/34327238 http://dx.doi.org/10.1155/2021/8569921

Ejemplares similares

Bioinformatics identification of potential candidate blood indicators for doxorubicin-induced heart failure
por: Wan, Guo-Xing, et al.
Publicado: (2018)

Multiple sessions of liposomal doxorubicin and focused ultrasound mediated blood-brain barrier disruption: safety study
por: Aryal, Muna, et al.
Publicado: (2015)

Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy
por: Zhou, Ji-Chao, et al.
Publicado: (2023)

Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy
por: Lódi, Mária, et al.
Publicado: (2019)

Doxorubicin-Induced Cardiomyopathy: A Preliminary Study on the Cardioprotective Benefits of 7-Hydroxyflavanone
por: Sangweni, Nonhlakanipho F., et al.
Publicado: (2023)

A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment
por: Chen, Yu, et al.
Publicado: (2015)

Hypertrophic cardiomyopathy with heart failure and ST‐segment elevation of the lateral wall
por: Bai, Lin, et al.
Publicado: (2022)

Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats
por: Li, Jinshuang, et al.
Publicado: (2021)

Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure
por: Oh, Chang-Myung, et al.
Publicado: (2019)

Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin
por: Jiang, Sai-Ping, et al.
Publicado: (2013)

Bovine Model of Doxorubicin-Induced Cardiomyopathy
por: Bartoli, Carlo R., et al.
Publicado: (2011)

Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
por: Luu, Albert Z., et al.
Publicado: (2018)

Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
por: Pillai, Vinodkumar B., et al.
Publicado: (2017)

Cardiac resynchronization therapy improves heart failure in one patient with acromegaly-induced cardiomyopathy: a case report
por: Wang, Jun yi, et al.
Publicado: (2019)

Naproxen aggravates doxorubicin-induced cardiomyopathy in rats
por: Pathan, Rahila Ahmad, et al.
Publicado: (2010)

Potential Therapeutic Treatments for Doxorubicin-Induced Cardiomyopathy
por: Kabir, Shadman, et al.
Publicado: (2022)

Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer
por: Wang, Bi-Lan, et al.
Publicado: (2013)

Development and verification of the nomogram for dilated cardiomyopathy gene diagnosis
por: Zhou, Li-qiang, et al.
Publicado: (2022)

Pathophysiological model of chronic heart failure complicated with renal failure caused by three-quarter nephrectomy and subcutaneous injection of isoprenaline
por: PENG, DING-FENG, et al.
Publicado: (2013)

Delivery of astragalus polysaccharide by ultrasound microbubbles attenuate doxorubicin-induced cardiomyopathy in rodent animals
por: Liu, Yanjie, et al.
Publicado: (2022)

Mapping the cardiac vascular niche in heart failure
por: Peisker, Fabian, et al.
Publicado: (2022)

Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart
por: Sun, Xi-Peng, et al.
Publicado: (2017)

Desmoplakin and clinical manifestations of desmoplakin cardiomyopathy
por: Yuan, Zhong-Yu, et al.
Publicado: (2021)

Overexpression of Nrdp1 in the Heart Exacerbates Doxorubicin-Induced Cardiac Dysfunction in Mice
por: Zhang, Yuan, et al.
Publicado: (2011)

Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice
por: Azam, Mohammed Ali, et al.
Publicado: (2021)

Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay
por: Schirone, Leonardo, et al.
Publicado: (2022)

Doxorubicin induced heart failure: Phenotype and molecular mechanisms
por: Mitry, Maria A., et al.
Publicado: (2015)

Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
por: Guo, Qian, et al.
Publicado: (2015)

A herbal formula, SYKT, reverses doxorubicin-induced myelosuppression and cardiotoxicity by inhibiting ROS-mediated apoptosis
por: Chen, Ting, et al.
Publicado: (2017)

Histone Demethylase JMJD3 Mediated Doxorubicin-Induced Cardiomyopathy by Suppressing SESN2 Expression
por: Wang, Panxia, et al.
Publicado: (2020)

Shengmai Injection Improved Doxorubicin-Induced Cardiomyopathy by Alleviating Myocardial Endoplasmic Reticulum Stress and Caspase-12 Dependent Apoptosis
por: Chen, Yu, et al.
Publicado: (2015)

Long noncoding RNA NEAT1 promotes cardiac fibrosis in heart failure through increased recruitment of EZH2 to the Smad7 promoter region
por: Ge, Zhuowang, et al.
Publicado: (2022)

Heart Failure in Patients with Arrhythmogenic Cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2021)

Exploring the Mechanism of Danshensu in the Treatment of Doxorubicin-Induced Cardiotoxicity Based on Network Pharmacology and Experimental Evaluation
por: Qi, Jia-ying, et al.
Publicado: (2022)

Trpc6 Promotes Doxorubicin-Induced Cardiomyopathy in Male Mice With Pleiotropic Differences Between Males and Females
por: Norton, Nadine, et al.
Publicado: (2022)

Correction: Overexpression of Nrdp1 in the Heart Exacerbates Doxorubicin-Induced Cardiac Dysfunction in Mice
por: Zhang, Yuan, et al.
Publicado: (2022)

CRISPR Disruption of BmOvo Resulted in the Failure of Emergence and Affected the Wing and Gonad Development in the Silkworm Bombyx mori
por: Bi, Honglun, et al.
Publicado: (2019)

Evaluation of hemodynamics in patients with hypertrophic cardiomyopathy by vector flow mapping: Comparison with healthy subjects
por: Cao, Yuan, et al.
Publicado: (2019)

Exploration the Mechanism of Doxorubicin-Induced Heart Failure in Rats by Integration of Proteomics and Metabolomics Data
por: Yuan, Yu, et al.
Publicado: (2020)

Adipose tissue homeostasis is deeply disrupted by doxorubicin treatment
por: Batatinha, Helena, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oqqftp3q6pvrm7h012ecrq41ki